Clinical Trial Update: Vaginal Progesterone in Twins With Short Cervix [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating vaginal progesterone to prevent preterm birth in twins with a short cervix has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Progesterone (vaginal) (progesterone)

Snippet

Sponsor: Obstetrix Medical Group | Conditions: Premature Birth | Phase 2, Phase 3 | Status: WITHDRAWN